### Analysis of Selection Pressures on rs34637584 (LRRK2 Variant)

The variant **rs34637584** is a well-known mutation in the **LRRK2** gene, associated with Parkinson's disease (PD). To assess the selection pressures acting on this variant, we can consider its allele frequency across populations, its functional impact, and its disease associations.

---

### 1. **Variant Identification**
- **rs Number**: [rs34637584](https://identifiers.org/dbsnp/rs34637584)
- **Gene**: LRRK2 (Leucine-Rich Repeat Kinase 2)
- **HGVS Notation**:
  - Protein: **p.Gly2019Ser** (ENSP00000298910.7:p.Gly2019Ser)
  - cDNA: **c.6055G>A** (ENST00000298910.12:c.6055G>A)
  - Genomic: **chr12:g.40340400G>A**
- **TogoVar Link**: [TogoVar rs34637584](https://togovar.org/variant/tgv45580587)

---

### 2. **Disease Associations**
- **Parkinson's Disease (PD)**: This variant is strongly associated with autosomal dominant Parkinson's disease (PD), particularly in late-onset and young-onset forms. It is classified as **Pathogenic (P)** in ClinVar.
- **Functional Impact**:
  - **SIFT**: 0.0 (deleterious)
  - **PolyPhen**: 1.0 (probably damaging)
  - **AlphaMissense**: 0.936 (high pathogenicity)

The pathogenic nature of this variant suggests that it may be under **negative selection** in populations where it is associated with disease.

---

### 3. **Allele Frequency Comparison**
- **Japanese Population**:
  - **ToMMo (Japanese)**: Allele frequency = 0.000028 (extremely rare)
  - **GEM-J WGA**: Allele frequency = 0.0000659
- **Non-Japanese Populations**:
  - **gnomAD Exomes**: Allele frequency = 0.0004166
  - **gnomAD Genomes**: Allele frequency = 0.0003614
  - **NCBN**: Allele frequency = 0.0001274

The variant is significantly rarer in Japanese populations compared to non-Japanese populations. This could indicate **population-specific selection pressures** or founder effects in certain populations.

---

### 4. **Selection Pressures**
- **Negative Selection**:
  - The pathogenic nature of rs34637584, leading to Parkinson's disease, suggests that it is likely under **negative selection** in most populations. Individuals carrying this variant may have reduced reproductive fitness due to the disease's impact on health and longevity.
- **Founder Effect**:
  - The variant is more common in certain populations, such as Ashkenazi Jews and North African Berbers, where it may have arisen due to a **founder effect**. In these populations, the variant may not have been strongly selected against historically, possibly due to smaller population sizes or genetic drift.
- **Balancing Selection**:
  - There is no evidence to suggest that rs34637584 confers any selective advantage, so balancing selection is unlikely to play a role.

---

### 5. **GWAS and Literature Evidence**
- **GWAS Findings**: This variant has been implicated in Parkinson's disease through multiple genome-wide association studies (GWAS).
- **Literature**: Numerous studies have documented the pathogenic role of rs34637584 in Parkinson's disease, particularly in familial cases. However, no evidence suggests a selective advantage for this variant.

---

### Conclusion
The rs34637584 variant in the **LRRK2** gene is likely under **negative selection** due to its strong association with Parkinson's disease. Its higher frequency in certain populations may be explained by a **founder effect** rather than positive selection. The rarity of this variant in Japanese populations further supports the idea of population-specific selection pressures.

---

### 日本語での説明

#### 選択圧とrs34637584
**rs34637584**は、**LRRK2**遺伝子における変異で、特にパーキンソン病（PD）との関連が知られています。この変異に対する選択圧を評価するために、集団間のアレル頻度、機能的影響、および疾患との関連性を考慮します。

---

### 1. **変異の特定**
- **rs番号**: [rs34637584](https://identifiers.org/dbsnp/rs34637584)
- **遺伝子**: LRRK2
- **HGVS表記**:
  - タンパク質: **p.Gly2019Ser**
  - cDNA: **c.6055G>A**
  - ゲノム: **chr12:g.40340400G>A**
- **TogoVarリンク**: [TogoVar rs34637584](https://togovar.org/variant/tgv45580587)

---

### 2. **疾患との関連**
- **パーキンソン病（PD）**: この変異は、特に遅発性および若年性のパーキンソン病と強く関連しています。ClinVarでは**病原性（P）**と分類されています。
- **機能的影響**:
  - **SIFT**: 0.0（有害）
  - **PolyPhen**: 1.0（おそらく有害）
  - **AlphaMissense**: 0.936（高い病原性）

この変異の病原性は、多くの集団で**負の選択圧**を受けている可能性を示唆しています。

---

### 3. **アレル頻度の比較**
- **日本人集団**:
  - **ToMMo**: アレル頻度 = 0.000028（非常に稀）
  - **GEM-J WGA**: アレル頻度 = 0.0000659
- **非日本人集団**:
  - **gnomAD Exomes**: アレル頻度 = 0.0004166
  - **gnomAD Genomes**: アレル頻度 = 0.0003614
  - **NCBN**: アレル頻度 = 0.0001274

この変異は、日本人集団では非日本人集団に比べて有意に稀であり、**集団特異的な選択圧**または創始者効果を示唆しています。

---

### 4. **選択圧**
- **負の選択圧**:
  - rs34637584の病原性（パーキンソン病の原因）は、多くの集団で**負の選択圧**を受けている可能性があります。
- **創始者効果**:
  - この変異は、アシュケナージ系ユダヤ人や北アフリカのベルベル人など、特定の集団でより一般的です。これらの集団では、歴史的に遺伝的浮動や小集団サイズのために強い選択圧を受けなかった可能性があります。
- **平衡選択**:
  - この変異が選択的優位性を持つ証拠はなく、平衡選択は関与していないと考えられます。

---

### 結論
**rs34637584**は、パーキンソン病との強い関連性から、**負の選択圧**を受けている可能性が高いです。一部の集団での高頻度は、**創始者効果**によるものである可能性があります。日本人集団での稀少性は、集団特異的な選択圧を支持しています。

